Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 731

1.

Statin Therapy and Risk of Intracranial Hemorrhage in Patients with Ischemic Stroke.

Florentin M, Elisaf MS.

Drug Saf. 2017 Jul 10. doi: 10.1007/s40264-017-0570-x. [Epub ahead of print] No abstract available.

PMID:
28695474
2.

Vorapaxar in secondary prevention: where we stand.

Kei A, Elisaf M.

Curr Med Res Opin. 2017 Jul 6:1-3. doi: 10.1080/03007995.2017.1341405. [Epub ahead of print] No abstract available.

PMID:
28604119
3.

Uncommon presentation of granulomatosis with polyangiitis in association with subclinical coeliac disease.

Voulgari PV, Apostolou F, Dounousi E, Liapis G, Elisaf M, Drosos AA.

Clin Exp Rheumatol. 2017 Jun 9. [Epub ahead of print]

PMID:
28598778
4.

Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences.

Tzavella E, Hatzimichael E, Kostara C, Bairaktari E, Elisaf M, Tsimihodimos V.

J Clin Lipidol. 2017 Apr 30. pii: S1933-2874(17)30254-4. doi: 10.1016/j.jacl.2017.04.116. [Epub ahead of print]

PMID:
28545928
5.

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Catapano AL.

Eur Heart J Suppl. 2016 Apr 12;18(Suppl C):C2-C12. doi: 10.1093/eurheartj/suw009.

6.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.

Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Review.

PMID:
28521870
7.

Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Filippas-Ntekouan S, Liberopoulos E, Elisaf M.

Infection. 2017 May 8. doi: 10.1007/s15010-017-1022-3. [Epub ahead of print] Review.

PMID:
28484991
8.

The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.

Barkas F, Elisaf M, Korantzopoulos P, Tsiara S, Liberopoulos E.

Int J Cardiol. 2017 Aug 15;241:194-199. doi: 10.1016/j.ijcard.2017.04.062. Epub 2017 Apr 20.

PMID:
28442233
9.

Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

Rizos EC, Elisaf MS.

Curr Cardiol Rep. 2017 Jun;19(6):47. doi: 10.1007/s11886-017-0856-8. Review.

PMID:
28432658
10.

Phosphate imbalance in patients with heart failure.

Christopoulou EC, Filippatos TD, Megapanou E, Elisaf MS, Liamis G.

Heart Fail Rev. 2017 May;22(3):349-356. doi: 10.1007/s10741-017-9615-6. Review.

PMID:
28432604
11.

Uncontrolled Hypertension and Oncology: Clinical Τips.

Kalaitzidis RG, Elisaf MS.

Curr Vasc Pharmacol. 2017 Apr 14. doi: 10.2174/1570161115666170414121436. [Epub ahead of print]

PMID:
28413967
12.

Incretins And Lipid Metabolism.

Tsimihodimos V, Elisaf MS.

Curr Med Chem. 2017 Apr 14. doi: 10.2174/0929867324666170414164244. [Epub ahead of print]

PMID:
28413961
13.

Serum osmolal gap in clinical practice: usefulness and limitations.

Liamis G, Filippatos TD, Liontos A, Elisaf MS.

Postgrad Med. 2017 May;129(4):456-459. doi: 10.1080/00325481.2017.1308210. Epub 2017 Mar 23. Review.

PMID:
28306366
14.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

PMID:
28304224
15.

NMR-Based Lipid Profiling of High Density Lipoprotein Particles in Healthy Subjects with Low, Normal, and Elevated HDL-Cholesterol.

Kostara CE, Tsimihodimos V, Elisaf MS, Bairaktari ET.

J Proteome Res. 2017 Apr 7;16(4):1605-1616. doi: 10.1021/acs.jproteome.6b00975. Epub 2017 Mar 21.

PMID:
28287268
16.

Antidiabetic Drugs and the Kidney.

Elisaf M, Tzavela E, Karanatsis N, Tsimihodimos V.

Curr Pharm Des. 2017 Mar 6. doi: 10.2174/1381612823666170307103222. [Epub ahead of print]

PMID:
28270062
17.

Statin escape phenomenon: Fact or fiction?

Barkas F, Elisaf M, Klouras E, Dimitriou T, Tentolouris N, Liberopoulos E.

World J Exp Med. 2017 Feb 20;7(1):25-30. doi: 10.5493/wjem.v7.i1.25. eCollection 2017 Feb 20.

18.

Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.

Kalaitzidis RG, Duni A, Liapis G, Balafa O, Xiromeriti S, Rapsomanikis PK, Elisaf MS.

Int Urol Nephrol. 2017 Feb 4. doi: 10.1007/s11255-017-1527-9. [Epub ahead of print] Review.

PMID:
28161838
19.

Pathophysiology of diabetic dyslipidaemia.

Filippatos T, Tsimihodimos V, Pappa E, Elisaf M.

Curr Vasc Pharmacol. 2017 Jan 31. doi: 10.2174/1570161115666170201105425. [Epub ahead of print]

PMID:
28155609
20.

Severe hyperkalemia following blood transfusions: Is there a link?

Rizos CV, Milionis HJ, Elisaf MS.

World J Nephrol. 2017 Jan 6;6(1):53-56. doi: 10.5527/wjn.v6.i1.53.

Supplemental Content

Loading ...
Support Center